Related Experiment Video

Updated: Jun 4, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Developmental and regenerative biology of multipotent cardiovascular progenitor cells

Anthony C Sturzu1, Sean M Wu

  • 1CPZN 3224 Simches Building, Massachusetts General Hospital, 185 Cambridge St, Boston, MA 02114, USA.

Circulation Research
|February 5, 2011
PubMed

Insights

Mammalian heart regeneration is limited, hindering heart failure treatment. Advances in cardiovascular progenitor cell biology offer hope for cardiac regeneration and treating cardiovascular disease.

Area of Science:

  • Cardiovascular biology
  • Regenerative medicine
  • Developmental biology

Background:

  • The mammalian heart has a limited capacity for regeneration, contributing to poor outcomes in heart failure.
  • Multipotent cardiovascular progenitor cells from various sources (embryonic, induced pluripotent stem cells) show promise for cardiovascular disease therapy.
  • Understanding the origin and properties of these progenitor cells is crucial for therapeutic development.

Purpose of the Study:

  • To review recent advances in cardiovascular progenitor cell biology.
  • To explore the implications of this understanding for therapeutic cardiac regeneration.
  • To highlight the role of cardiogenesis in future heart failure therapies.

Main Methods:

  • Review of scientific literature on cardiovascular progenitor cell biology.
  • Analysis of developmental processes from embryogenesis to adulthood.
  • Synthesis of findings related to cell origin, properties, and therapeutic potential.

Main Results:

  • Identification of distinct families of multipotent cardiovascular progenitor cells.
  • Clarification of the origin and properties of cells with cardiogenic potential.
  • Advances in understanding cell biology from embryonic development through adulthood.

Conclusions:

  • Detailed understanding of cardiogenesis is essential for advancing cardiovascular progenitor cell applications.
  • Therapeutic manipulation of these cells holds significant potential for heart failure treatment.
  • Future regenerative medicine strategies will likely leverage insights into cardiovascular progenitor cell biology.

More Related Videos

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue08:15

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...